What a stem cell injection for back pain is
Most back pain stem cell procedures target the intervertebral disc, the cushion between two vertebrae. As discs age, they lose water and height and can crack, and a disc that hurts on its own is called discogenic pain. The idea is that injected cells might calm inflammation in the disc or help it repair.
The cells used fall into three groups:
- Your own bone marrow concentrate (BMAC). Marrow is drawn from the back of the hip, concentrated in a centrifuge and injected the same day. Read what BMAC is.
- Your own cultured cells. Cells are grown in a lab over several weeks. Under FDA rules, cultured cells can be given in the U.S. only within an FDA-authorized trial.
- Donor cells. Cells from another person's bone marrow, or birth tissue such as umbilical cord, made in a lab.
Less often, cells are injected into the small facet joints at the back of the spine or the sacroiliac joints where the spine meets the pelvis. For the background, read what stem cell therapy is.
What the trials show
Several placebo-controlled trials have tested cells in the disc, and the larger ones tell a consistent story:
| Cell type | Best trial | What it found |
|---|---|---|
| Your own bone marrow concentrate (BMAC) | Sham-controlled trial, 63 patients, 2025 | No better than a sham procedure at 12 months |
| Donor bone marrow cells | Sham-controlled trial, 114 patients, 2024 | Responders 74% vs. 69% with sham; no difference |
| Donor precursor cells (rexlemestrocel-L) | Phase 3 trial, 404 patients, 2025 | Missed its main goal; lower pain at 12 and 24 months in one arm |
| Your own cultured cells | Sham-controlled trial, 52 patients, 2025 | Disc height rose; pain and function no different from sham |
| Facet and sacroiliac joints | Facet: one 10-patient trial with no control group. Sacroiliac: none | Unknown |
Bone marrow concentrate into the disc
The first results were striking. In a 2015 open-label study, 26 patients with disc pain had their own bone marrow concentrate injected into the disc. Their disability scores fell by more than half at one year. At three years, 6 of the 26 had gone on to surgery, and the other 20 kept most of their improvement.
Open-label studies cannot separate the cells from the placebo effect, time and the attention that comes with a procedure. A 2025 double-blind trial tested exactly that: 63 patients were randomized to bone marrow concentrate or a sham procedure. At twelve months, 44% of the bone marrow group and 56% of the sham group had at least half their pain relieved. The authors concluded the two were equivalent.
Donor cells
A 2017 Spanish trial of 24 patients compared donor bone marrow cells with a sham injection into the back muscles and found improvement only in a subset of responders. The larger European RESPINE trial, published in 2024, randomized 114 patients to donor bone marrow cells or a sham. At one year, 74% of the cell group and 69% of the sham group met the definition of a responder, and no secondary outcome differed.
Rexlemestrocel-L, the leading drug candidate
Mesoblast's rexlemestrocel-L is a donor cell product being developed as a prescription drug for disc pain. In a 100-patient phase 2 trial, the cell groups did better than controls on pain and disability at several points over three years, while disc imaging showed no difference between groups. The 404-patient phase 3 trial, published in 2025, missed its main composite goal. Patients given cells with hyaluronic acid had lower average pain than saline at 12 and 24 months, with larger effects in people who had been in pain for less than 68 months (about five years and eight months). Among patients taking opioids at the start, 28% of that group were off them at three years, against 8% with saline.
A second phase 3 trial, designed with the FDA, has finished treating its patients, and the company expects results in mid-2027. Until it is approved, the product is not available to new patients.
Cultured cells
A 2025 Italian trial gave 52 patients their own lab-grown marrow cells or a sham. Disc height increased in the cell group, but pain, function and quality of life were no different from sham at six months.
Facet and sacroiliac joints
The evidence here is thinner. The only published facet joint stem cell trial is a 10-patient study with no control group, in which six patients met its pain goal at two years. I am not aware of any sacroiliac joint stem cell trial.
What the evidence adds up to
A 2026 review of 13 randomized trials found that a patient's own bone marrow concentrate and cells did no better than sham, and called donor precursor cells the most promising approach while still investigational. People in these trials often improved a great deal, but people given the sham improved nearly as much. Any clinic that cites only the open-label results is leaving out the trials that matter most.
What to try first for chronic back pain
The American College of Physicians recommends starting with treatments that do not involve drugs: exercise, multidisciplinary rehab, acupuncture, mindfulness, yoga or tai chi, cognitive behavioral therapy, or spinal manipulation. If those are not enough, anti-inflammatory medicines come next. Opioids are a last resort.
Before any injection, the source of the pain should be clear. Disc, facet joint, sacroiliac joint, nerve and muscle pain are treated differently, and an MRI showing a worn disc does not prove the disc is the cause. A large review of people without back pain found disc wear on imaging in about a third of 20-year-olds and most people over 50.
Risks and side effects
- Disc injury from the needle. A 10-year study found that discs punctured during diagnostic testing degenerated more (35% vs. 14%) and herniated more often than discs left alone.
- Infection. Disc infection is rare but serious. In 2018 the CDC linked infections in 12 patients, including epidural abscesses and disc infections after spinal injections, to contaminated umbilical cord blood-derived products.
- Unregulated products. A 2016 report in the New England Journal of Medicine described a man who developed a growth on his spinal cord after stem cells were injected into his spinal fluid at clinics in China, Argentina and Mexico.
- Soreness at the hip and the back for several days is expected after the procedure.
In the controlled trials above, serious treatment-related adverse events were uncommon. Your own cells, processed the same day under sterile conditions and placed with X-ray guidance, carry a different risk profile from a donor product of unknown origin.
How much it costs
I am not aware of published price data for spine stem cell procedures. The best-known published figure is for the knee, where researchers posing as patients found U.S. clinics quoted $5,156 on average for one knee. Disc injections usually need X-ray guidance and a procedure room, which raises the price, and insurance generally does not pay. For what drives the price, read how much stem cell therapy costs.
Questions to ask before a stem cell injection for your back
- What is causing my pain, and how was that confirmed?
- What cells are you using, and where do they come from?
- What did the sham-controlled trials show for this procedure?
- Have I had a full course of rehab and exercise therapy?
- Who performs the injection, and is it guided by X-ray?
- What is the total cost, and what happens if it does not help?
For what Florida law allows and what to check about a donor product, read is stem cell therapy legal in Florida?
Back pain evaluations with me in Miami
I am a sports medicine physician, board-certified by the American Board of Family Medicine, and my practice focuses on non-surgical orthopedics. For back pain, that starts with finding the source: a hands-on exam, a review of your imaging, and a plan built around rehab. Given the trials above, I am cautious about cell injections into the disc, and I will tell you plainly which options are worth your money.
My online consultations are $300 for 30 minutes and $600 for 60 minutes, for patients located in Florida or Tennessee. See stem cell therapy in Miami, or book a consultation.
Frequently asked questions
Do stem cell injections work for back pain?
Not convincingly yet. Open-label studies of disc injections reported large improvements, but in the larger trials that compared cells with a sham or saline injection, patients did about as well with the placebo. Three such trials, with 63, 114 and 404 patients, missed their main goal. In the largest, other analyses favored cells given with hyaluronic acid, including lower average pain at 12 and 24 months, and a second large trial has finished treating patients.
Can stem cells regenerate a degenerated disc?
There is no good evidence that they do in people. In the 100-patient phase 2 trial of donor precursor cells, disc imaging showed no difference between the cell and control groups. A 2025 trial of cultured cells found a rise in disc height, but pain and function were no different from sham.
Are stem cell injections for back pain FDA-approved?
No. No stem cell product is FDA-approved for back pain or disc disease, and the FDA names back pain specifically in its warning about unapproved regenerative therapies. The leading candidate, Mesoblast's rexlemestrocel-L, is in a second phase 3 trial, with results expected in mid-2027.
What are the risks of a stem cell injection in the spine?
Any needle into the disc carries a small risk of infection, and a 10-year study found discs punctured during testing degenerated and herniated more often. Unregulated products have caused serious infections and, in one reported case, a growth on the spinal cord after injections abroad. Your own cells, processed the same day under sterile conditions, carry a different risk profile from a donor product of unknown origin.
How much does a stem cell injection for back pain cost?
I am not aware of a published average for spine procedures. The best-known published figure is for the knee, where researchers posing as patients found U.S. clinics quoted $5,156 on average for one knee. Spine injections usually need X-ray guidance and a procedure room, which raises the price, and insurance generally does not pay.
What should I try before stem cells for back pain?
The American College of Physicians recommends starting chronic low back pain treatment with exercise, rehab, and options such as acupuncture, yoga, tai chi or spinal manipulation, then anti-inflammatory medicines if those are not enough. An accurate diagnosis of where the pain comes from matters more than any injection.
Is PRP better than stem cells for back pain?
Neither has strong evidence in the spine. A small open-label study reported both bone marrow concentrate and PRP did better than a saline injection into muscle, but its design was weak. No large sham-controlled trial has compared them.
Sources
- Levi D et al. Bone marrow concentrate intradiscal injection for chronic discogenic low back pain: a double-blind randomized sham-controlled trial. Interv Pain Med, 2025
- Pers YM et al. Allogenic bone marrow-derived mesenchymal stromal cell-based therapy for patients with chronic low back pain: a prospective, multicentre, randomised placebo controlled trial (RESPINE study). Ann Rheum Dis, 2024
- Beall DP et al. Efficacy and safety of allogeneic mesenchymal precursor cells with and without hyaluronic acid for treatment of chronic low back pain: a prospective, randomized, double blind, concurrent-controlled 36-month study. Spine J, 2025
- Amirdelfan K et al. Allogeneic mesenchymal precursor cells treatment for chronic low back pain associated with degenerative disc disease: a prospective randomized, placebo-controlled 36-month study of safety and efficacy. Spine J, 2021
- Vadalà G et al. Intradiscal mesenchymal stromal cell therapy for the treatment of low back pain due to moderate-to-advanced multilevel disc degeneration: a preliminary report of a double-blind, phase IIB randomized clinical trial (DREAM study). JOR Spine, 2025
- Noriega DC et al. Intervertebral disc repair by allogeneic mesenchymal bone marrow cells: a randomized controlled trial. Transplantation, 2017
- Pettine KA et al. Percutaneous injection of autologous bone marrow concentrate cells significantly reduces lumbar discogenic pain through 12 months. Stem Cells, 2015
- Pettine KA et al. Autologous bone marrow concentrate intradiscal injection for the treatment of degenerative disc disease with three-year follow-up. Int Orthop, 2017
- Zhang RE, Aurangzeb A, Sirisena D. Platelet-rich plasma and stem cell therapies for spondylosis: a systematic review of randomized controlled trials. Eur Spine J, 2026
- Qu W et al. Intra-articular delivery of allogeneic bone marrow derived mesenchymal stromal cells (BM-MSCs) for painful lumbar facet arthropathy: a phase I clinical trial. Stem Cell Res Ther, 2025
- Carragee EJ et al. 2009 ISSLS Prize Winner: does discography cause accelerated progression of degeneration changes in the lumbar disc: a ten-year matched cohort study. Spine, 2009
- Berkowitz AL et al. Glioproliferative lesion of the spinal cord as a complication of "stem-cell tourism". N Engl J Med, 2016
- CDC. Bacterial infections linked to the use of stem cell products, United States, 2018. MMWR, 2018
- FDA: Important patient and consumer information about regenerative medicine therapies
- Navani A et al. The safety and effectiveness of orthobiologic injections for discogenic chronic low back pain: a multicenter prospective, crossover, randomized controlled trial with 12 months follow-up. Pain Physician, 2024
- Brinjikji W et al. Systematic literature review of imaging features of spinal degeneration in asymptomatic populations. AJNR Am J Neuroradiol, 2015
- Qaseem A et al. Noninvasive treatments for acute, subacute, and chronic low back pain: a clinical practice guideline from the American College of Physicians. Ann Intern Med, 2017
- Piuzzi NS et al. The stem-cell market for the treatment of knee osteoarthritis: a patient perspective. J Knee Surg, 2018
